Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) EBT: 2020-2024

Historic EBT for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to -$12.9 million.

  • iSpecimen's EBT fell 65.34% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.3 million, marking a year-over-year decrease of 26.75%. This contributed to the annual value of -$12.9 million for FY2024, which is 18.55% down from last year.
  • According to the latest figures from FY2024, iSpecimen's EBT is -$12.9 million, which was down 18.55% from -$10.8 million recorded in FY2023.
  • iSpecimen's EBT's 5-year high stood at -$4.5 million during FY2020, with a 5-year trough of -$12.9 million in FY2024.
  • In the last 3 years, iSpecimen's EBT had a median value of -$10.8 million in 2023 and averaged -$11.3 million.
  • Data for iSpecimen's EBT shows a maximum YoY crashed of 78.04% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows iSpecimen's EBT stood at -$4.5 million in 2020, then tumbled by 78.04% to -$8.0 million in 2021, then decreased by 27.93% to -$10.3 million in 2022, then decreased by 5.75% to -$10.8 million in 2023, then dropped by 18.55% to -$12.9 million in 2024.